Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer
Clinical trial NCT06146985 · UNKNOWN
Trial details
- NCT number
- NCT06146985
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-11-15
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.